Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
<p>Abstract</p> <p>Background</p> <p>Treatments for uncomplicated falciparum malaria should have high cure rates. The World Health Organization has recently set a target cure rate of 95% assessed at 28 days. The use of more effective drugs, with longer periods of patien...
Main Authors: | Stepniewska Kasia, White Nicholas J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-12-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/5/1/127 |
Similar Items
-
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.
by: Stepniewska, K, et al.
Published: (2006) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
by: Steffen Borrmann, et al.
Published: (2008-11-01) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
by: Borrmann, S, et al.
Published: (2008) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
by: Borrmann, S, et al.
Published: (2008) -
Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria.
by: Pukrittayakamee, S, et al.
Published: (2003)